These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 28174092)

  • 21. Colorectal cancer models for novel drug discovery.
    Golovko D; Kedrin D; Yilmaz ÖH; Roper J
    Expert Opin Drug Discov; 2015; 10(11):1217-29. PubMed ID: 26295972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response.
    Gao H; Korn JM; Ferretti S; Monahan JE; Wang Y; Singh M; Zhang C; Schnell C; Yang G; Zhang Y; Balbin OA; Barbe S; Cai H; Casey F; Chatterjee S; Chiang DY; Chuai S; Cogan SM; Collins SD; Dammassa E; Ebel N; Embry M; Green J; Kauffmann A; Kowal C; Leary RJ; Lehar J; Liang Y; Loo A; Lorenzana E; Robert McDonald E; McLaughlin ME; Merkin J; Meyer R; Naylor TL; Patawaran M; Reddy A; Röelli C; Ruddy DA; Salangsang F; Santacroce F; Singh AP; Tang Y; Tinetto W; Tobler S; Velazquez R; Venkatesan K; Von Arx F; Wang HQ; Wang Z; Wiesmann M; Wyss D; Xu F; Bitter H; Atadja P; Lees E; Hofmann F; Li E; Keen N; Cozens R; Jensen MR; Pryer NK; Williams JA; Sellers WR
    Nat Med; 2015 Nov; 21(11):1318-25. PubMed ID: 26479923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Patient-derived xenografts as tools in pharmaceutical development.
    Izumchenko E; Meir J; Bedi A; Wysocki PT; Hoque MO; Sidransky D
    Clin Pharmacol Ther; 2016 Jun; 99(6):612-21. PubMed ID: 26874468
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of patient-derived tumor xenograft models of endometrial cancer for preclinical evaluation of targeted therapies.
    Depreeuw J; Hermans E; Schrauwen S; Annibali D; Coenegrachts L; Thomas D; Luyckx M; Gutierrez-Roelens I; Debruyne D; Konings K; Moerman P; Vergote I; Lambrechts D; Amant F
    Gynecol Oncol; 2015 Oct; 139(1):118-26. PubMed ID: 26232337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anti-tumor activity of a novel monoclonal antibody, NPC-1C, optimized for recognition of tumor antigen MUC5AC variant in preclinical models.
    Patel SP; Bristol A; Saric O; Wang XP; Dubeykovskiy A; Arlen PM; Morse MA
    Cancer Immunol Immunother; 2013 Jun; 62(6):1011-9. PubMed ID: 23591984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of Combined Treatment with Ionizing Radiation and the PARP Inhibitor Olaparib in BRCA Mutant and Wild Type Patient-Derived Pancreatic Cancer Xenografts.
    Lohse I; Kumareswaran R; Cao P; Pitcher B; Gallinger S; Bristow RG; Hedley DW
    PLoS One; 2016; 11(12):e0167272. PubMed ID: 28033382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Individualized drug screening based on next generation sequencing and patient derived xenograft model for pancreatic cancer with bone metastasis.
    Guan Z; Lan H; Chen X; Jiang X; Wang X; Jin K
    Mol Med Rep; 2017 Oct; 16(4):4784-4790. PubMed ID: 28849200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Triptolide augments the effects of 5-lipoxygenase RNA interference in suppressing pancreatic tumor growth in a xenograft mouse model.
    Ding X; Zhou X; Zhang H; Qing J; Qiang H; Zhou G
    Cancer Chemother Pharmacol; 2012 Jan; 69(1):253-61. PubMed ID: 21713446
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complete tumor response following intratumoral 32P BioSilicon on human hepatocellular and pancreatic carcinoma xenografts in nude mice.
    Zhang K; Loong SL; Connor S; Yu SW; Tan SY; Ng RT; Lee KM; Canham L; Chow PK
    Clin Cancer Res; 2005 Oct; 11(20):7532-7. PubMed ID: 16243828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted delivery of chemotherapy using HSP90 inhibitor drug conjugates is highly active against pancreatic cancer models.
    Bobrov E; Skobeleva N; Restifo D; Beglyarova N; Cai KQ; Handorf E; Campbell K; Proia DA; Khazak V; Golemis EA; Astsaturov I
    Oncotarget; 2017 Jan; 8(3):4399-4409. PubMed ID: 27779106
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Small molecule XIAP inhibitors enhance TRAIL-induced apoptosis and antitumor activity in preclinical models of pancreatic carcinoma.
    Vogler M; Walczak H; Stadel D; Haas TL; Genze F; Jovanovic M; Bhanot U; Hasel C; Möller P; Gschwend JE; Simmet T; Debatin KM; Fulda S
    Cancer Res; 2009 Mar; 69(6):2425-34. PubMed ID: 19258513
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Augmentation of response to nab-paclitaxel by inhibition of insulin-like growth factor (IGF) signaling in preclinical pancreatic cancer models.
    Awasthi N; Scire E; Monahan S; Grojean M; Zhang E; Schwarz MA; Schwarz RE
    Oncotarget; 2016 Jul; 7(30):46988-47001. PubMed ID: 27127884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational value of mouse models in oncology drug development.
    Gould SE; Junttila MR; de Sauvage FJ
    Nat Med; 2015 May; 21(5):431-9. PubMed ID: 25951530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patient-derived xenografts from non-small cell lung cancer brain metastases are valuable translational platforms for the development of personalized targeted therapy.
    Lee HW; Lee JI; Lee SJ; Cho HJ; Song HJ; Jeong DE; Seo YJ; Shin S; Joung JG; Kwon YJ; Choi YL; Park WY; Lee HM; Seol HJ; Shim YM; Joo KM; Nam DH
    Clin Cancer Res; 2015 Mar; 21(5):1172-82. PubMed ID: 25549722
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bmi-1 promotes the chemoresistance, invasion and tumorigenesis of pancreatic cancer cells.
    Yin T; Wei H; Leng Z; Yang Z; Gou S; Wu H; Zhao G; Hu X; Wang C
    Chemotherapy; 2011; 57(6):488-96. PubMed ID: 22248802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mimosine, a plant-derived amino acid induces apoptosis in human pancreatic cancer xenografts.
    Zalatnai A; Bocsi J
    Anticancer Res; 2003; 23(5A):4007-9. PubMed ID: 14666710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Testing PARP Inhibitors Using a Murine Xenograft Model.
    Makhov P; Naito S; Kolenko VM
    Methods Mol Biol; 2017; 1608():313-320. PubMed ID: 28695518
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical models for translational sarcoma research.
    Hamacher R; Bauer S
    Curr Opin Oncol; 2017 Jul; 29(4):275-285. PubMed ID: 28445233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient-derived xenograft in zebrafish embryos: a new platform for translational research in neuroendocrine tumors.
    Gaudenzi G; Albertelli M; Dicitore A; Würth R; Gatto F; Barbieri F; Cotelli F; Florio T; Ferone D; Persani L; Vitale G
    Endocrine; 2017 Aug; 57(2):214-219. PubMed ID: 27481363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.